Global Hemostatic Agents Market Analysis 2016-2020 and Forecast 2021-2026
- Report Code : 99S2466205
- Published On: Apr, 2021
- Category : Healthcare & Pharma
- Pages : 141
-
The global Hemostatic Agents market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hemostatic Agents by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Oxidized Regenerated Cellulose
Combination
Gelatin
Thrombin
Collagen
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Baxter International Incorporation
C.R. Bard Incorporation
B.Braun Melsungen AG
Integra Life Sciences Corporation
Equimedical
Marine Polymer Technologies
Gelita GmbH
Pfizer Inc
Advanced Medical Solutions Group
Vascular Solutions, Inc
Z-Medica LLC
Mallinckrodt Plc
Covidien PLC.
Atrium Medical Corporation
Sanofi Group
Cryolife, Inc.
Hemostasis, LLC
Ethicon
The Medicines Company
Anika Therapeutics
Biom'Up SAS
BioCer Entwicklungs
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Surgical Centers
Nursing Homes
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
-
With tables and figures helping analyze worldwide Global Hemostatic Agents market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview1.1 Hemostatic Agents Industry
Figure Hemostatic Agents Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Hemostatic Agents1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Hemostatic Agents
1.2.2 Downstream
Table Application Segment of Hemostatic Agents
Table Global Hemostatic Agents Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact1.3 Cost Analysis
2 Industry Environment (PEST Analysis)2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Hemostatic Agents Market by Type3.1 By Type
3.1.1 Oxidized Regenerated Cellulose
Table Major Company List of Oxidized Regenerated Cellulose
3.1.2 Combination
Table Major Company List of Combination
3.1.3 Gelatin
Table Major Company List of Gelatin
3.1.4 Thrombin
Table Major Company List of Thrombin
3.1.5 Collagen
Table Major Company List of Collagen
3.1.6 Others
Table Major Company List of Others3.2 Market Size
Table Global Hemostatic Agents Market 2016-2020, by Type, in USD Million
Figure Global Hemostatic Agents Market Growth 2016-2020, by Type, in USD Million
Table Global Hemostatic Agents Market 2016-2020, by Type, in Volume
Figure Global Hemostatic Agents Market Growth 2016-2020, by Type, in Volume3.3 Market Forecast
Table Global Hemostatic Agents Market Forecast 2021-2026, by Type, in USD Million
Table Global Hemostatic Agents Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List4.1 Baxter International Incorporation (Company Profile, Sales Data etc.)
4.1.1 Baxter International Incorporation Profile
Table Baxter International Incorporation Overview List
4.1.2 Baxter International Incorporation Products & Services
4.1.3 Baxter International Incorporation Business Operation Conditions
Table Business Operation of Baxter International Incorporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 C.R. Bard Incorporation (Company Profile, Sales Data etc.)
4.2.1 C.R. Bard Incorporation Profile
Table C.R. Bard Incorporation Overview List
4.2.2 C.R. Bard Incorporation Products & Services
4.2.3 C.R. Bard Incorporation Business Operation Conditions
Table Business Operation of C.R. Bard Incorporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 B.Braun Melsungen AG (Company Profile, Sales Data etc.)
4.3.1 B.Braun Melsungen AG Profile
Table B.Braun Melsungen AG Overview List
4.3.2 B.Braun Melsungen AG Products & Services
4.3.3 B.Braun Melsungen AG Business Operation Conditions
Table Business Operation of B.Braun Melsungen AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 Integra Life Sciences Corporation (Company Profile, Sales Data etc.)
4.4.1 Integra Life Sciences Corporation Profile
Table Integra Life Sciences Corporation Overview List
4.4.2 Integra Life Sciences Corporation Products & Services
4.4.3 Integra Life Sciences Corporation Business Operation Conditions
Table Business Operation of Integra Life Sciences Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 Equimedical (Company Profile, Sales Data etc.)
4.5.1 Equimedical Profile
Table Equimedical Overview List
4.5.2 Equimedical Products & Services
4.5.3 Equimedical Business Operation Conditions
Table Business Operation of Equimedical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Marine Polymer Technologies (Company Profile, Sales Data etc.)
4.6.1 Marine Polymer Technologies Profile
Table Marine Polymer Technologies Overview List
4.6.2 Marine Polymer Technologies Products & Services
4.6.3 Marine Polymer Technologies Business Operation Conditions
Table Business Operation of Marine Polymer Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Gelita GmbH (Company Profile, Sales Data etc.)
4.7.1 Gelita GmbH Profile
Table Gelita GmbH Overview List
4.7.2 Gelita GmbH Products & Services
4.7.3 Gelita GmbH Business Operation Conditions
Table Business Operation of Gelita GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc Profile
Table Pfizer Inc Overview List
4.8.2 Pfizer Inc Products & Services
4.8.3 Pfizer Inc Business Operation Conditions
Table Business Operation of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Advanced Medical Solutions Group (Company Profile, Sales Data etc.)
4.9.1 Advanced Medical Solutions Group Profile
Table Advanced Medical Solutions Group Overview List
4.9.2 Advanced Medical Solutions Group Products & Services
4.9.3 Advanced Medical Solutions Group Business Operation Conditions
Table Business Operation of Advanced Medical Solutions Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 Vascular Solutions, Inc (Company Profile, Sales Data etc.)
4.10.1 Vascular Solutions, Inc Profile
Table Vascular Solutions, Inc Overview List
4.10.2 Vascular Solutions, Inc Products & Services
4.10.3 Vascular Solutions, Inc Business Operation Conditions
Table Business Operation of Vascular Solutions, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Z-Medica LLC (Company Profile, Sales Data etc.)
4.11.1 Z-Medica LLC Profile
Table Z-Medica LLC Overview List
4.11.2 Z-Medica LLC Products & Services
4.11.3 Z-Medica LLC Business Operation Conditions
Table Business Operation of Z-Medica LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Mallinckrodt Plc (Company Profile, Sales Data etc.)
4.12.1 Mallinckrodt Plc Profile
Table Mallinckrodt Plc Overview List
4.12.2 Mallinckrodt Plc Products & Services
4.12.3 Mallinckrodt Plc Business Operation Conditions
Table Business Operation of Mallinckrodt Plc (Sales Revenue, Cost, Gross Margin)
4.13 Covidien PLC. (Company Profile, Sales Data etc.)
4.13.1 Covidien PLC. Profile
Table Covidien PLC. Overview List
4.13.2 Covidien PLC. Products & Services
4.13.3 Covidien PLC. Business Operation Conditions
Table Business Operation of Covidien PLC. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Atrium Medical Corporation (Company Profile, Sales Data etc.)
4.14.1 Atrium Medical Corporation Profile
Table Atrium Medical Corporation Overview List
4.14.2 Atrium Medical Corporation Products & Services
4.14.3 Atrium Medical Corporation Business Operation Conditions
Table Business Operation of Atrium Medical Corporation (Sales Revenue, Cost, Gross Margin)
4.15 Sanofi Group (Company Profile, Sales Data etc.)
4.15.1 Sanofi Group Profile
Table Sanofi Group Overview List
4.15.2 Sanofi Group Products & Services
4.15.3 Sanofi Group Business Operation Conditions
Table Business Operation of Sanofi Group (Sales Revenue, Cost, Gross Margin)
4.16 Cryolife, Inc. (Company Profile, Sales Data etc.)
4.16.1 Cryolife, Inc. Profile
Table Cryolife, Inc. Overview List
4.16.2 Cryolife, Inc. Products & Services
4.16.3 Cryolife, Inc. Business Operation Conditions
Table Business Operation of Cryolife, Inc. (Sales Revenue, Cost, Gross Margin)
4.17 Hemostasis, LLC (Company Profile, Sales Data etc.)
4.17.1 Hemostasis, LLC Profile
Table Hemostasis, LLC Overview List
4.17.2 Hemostasis, LLC Products & Services
4.17.3 Hemostasis, LLC Business Operation Conditions
Table Business Operation of Hemostasis, LLC (Sales Revenue, Cost, Gross Margin)
4.18 Ethicon (Company Profile, Sales Data etc.)
4.18.1 Ethicon Profile
Table Ethicon Overview List
4.18.2 Ethicon Products & Services
4.18.3 Ethicon Business Operation Conditions
Table Business Operation of Ethicon (Sales Revenue, Cost, Gross Margin)
4.19 The Medicines Company (Company Profile, Sales Data etc.)
4.19.1 The Medicines Company Profile
Table The Medicines Company Overview List
4.19.2 The Medicines Company Products & Services
4.19.3 The Medicines Company Business Operation Conditions
Table Business Operation of The Medicines Company (Sales Revenue, Cost, Gross Margin)4.20 Anika Therapeutics (Company Profile, Sales Data etc.)
4.20.1 Anika Therapeutics Profile
Table Anika Therapeutics Overview List
4.20.2 Anika Therapeutics Products & Services
4.20.3 Anika Therapeutics Business Operation Conditions
Table Business Operation of Anika Therapeutics (Sales Revenue, Cost, Gross Margin)
4.21 Biom'Up SAS (Company Profile, Sales Data etc.)
4.21.1 Biom'Up SAS Profile
Table Biom'Up SAS Overview List
4.21.2 Biom'Up SAS Products & Services
4.21.3 Biom'Up SAS Business Operation Conditions
Table Business Operation of Biom'Up SAS (Sales Revenue, Cost, Gross Margin)
4.22 BioCer Entwicklungs (Company Profile, Sales Data etc.)
4.22.1 BioCer Entwicklungs Profile
Table BioCer Entwicklungs Overview List
4.22.2 BioCer Entwicklungs Products & Services
4.22.3 BioCer Entwicklungs Business Operation Conditions
Table Business Operation of BioCer Entwicklungs (Sales Revenue, Cost, Gross Margin)
5 Market Competition5.1 Company Competition
Table Global Hemostatic Agents Sales Revenue 2016-2020, by Company, in USD Million
Table Global Hemostatic Agents Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Hemostatic Agents Sales Revenue Share in 2020, by Company, in USD Million
Table Global Hemostatic Agents Sales Volume 2016-2020, by Company, in Volume
Table Global Hemostatic Agents Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Hemostatic Agents Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by Company
Figure North America Hemostatic Agents Market Concentration, in 2020
Figure Europe Hemostatic Agents Market Market Concentration, in 2020
Figure Asia-Pacific Hemostatic Agents MMarket Concentration, in 2020
Figure South America Hemostatic Agents Market Concentration, in 2020
Figure Middle East & Africa Hemostatic Agents Market Concentration, in 2020
6 Demand by End Market6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Hemostatic Agents Demand in Hospitals, 2016-2020, in USD Million
Figure Hemostatic Agents Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Surgical Centers
Figure Hemostatic Agents Demand in Surgical Centers, 2016-2020, in USD Million
Figure Hemostatic Agents Demand in Surgical Centers, 2016-2020, in Volume
6.1.3 Demand in Nursing Homes
Figure Hemostatic Agents Demand in Nursing Homes, 2016-2020, in USD Million
Figure Hemostatic Agents Demand in Nursing Homes, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Hemostatic Agents Demand in Others, 2016-2020, in USD Million
Figure Hemostatic Agents Demand in Others, 2016-2020, in Volume6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions6.3 Demand Forecast
Table Hemostatic Agents Demand Forecast 2021-2026, by Application, in USD Million
Figure Hemostatic Agents Market Growth 2021-2026, by Application, in USD Million
Figure Hemostatic Agents Market Share in 2026, by Application, in USD Million
Table Hemostatic Agents Demand Forecast 2021-2026, by Application, in Volume
Table Hemostatic Agents Market Growth 2021-2026, by Application, in Volume
Table Hemostatic Agents Market Share in 2026, by Application, in Volume6.4 Impact of the COVID-19 on the Demand
7 Region Operation7.1 Regional Production
Table Hemostatic Agents Production 2016-2020, by Region, in USD Million
Table Hemostatic Agents Production 2016-2020, by Region, in Volume7.2 Regional Market
Table Global Hemostatic Agents Market 2016-2020, by Region, in USD Million
Table Global Hemostatic Agents Market Share 2016-2020, by Region, in USD Million
Table Global Hemostatic Agents Market 2016-2020, by Region, in Volume
Table Global Hemostatic Agents Market Share 2016-2020, by Region, in Volume7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Hemostatic Agents Market Size and Growth 2016-2020, in USD Million
Figure North America Hemostatic Agents Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Hemostatic Agents Market Size 2016-2020, by Country, in USD Million
Table North America Hemostatic Agents Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Hemostatic Agents Market Size and Growth 2016-2020, in USD Million
Figure Europe Hemostatic Agents Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Hemostatic Agents Market Size 2016-2020, by Country, in USD Million
Table Europe Hemostatic Agents Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Hemostatic Agents Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Hemostatic Agents Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Hemostatic Agents Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Hemostatic Agents Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Hemostatic Agents Market Size and Growth 2016-2020, in USD Million
Figure South America Hemostatic Agents Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Hemostatic Agents Market Size 2016-2020, by Country, in USD Million
Table South America Hemostatic Agents Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Hemostatic Agents Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Hemostatic Agents Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Hemostatic Agents Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Hemostatic Agents Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export
7.5 Regional Forecast
Table Hemostatic Agents Market Forecast 2021-2026, by Region, in USD Million
Table Hemostatic Agents Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
-
The Global Hemostatic Agents Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
The Global Hemostatic Agents Market study evaluates the year spans as follows: Historical year: 2017 to 2022; Base year: 2022; Forecast period**: 2023 to 2028 [** unless otherwise stated]
The value of the Global Hemostatic Agents Market is estimated to be USD XXX million.
The majority of data for the Global Hemostatic Agents Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
